|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 495/04 | (2006.01) |
| A61K 31/407 | (2006.01) | ||
| A61P 25/16 | (2006.01) |
| (11) | Number of the document | 3186257 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15770814.0 |
| Date of filing the European patent application | 2015-08-27 | |
| (97) | Date of publication of the European application | 2017-07-05 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-06 |
| (46) | Date of publication of the claims translation | 2019-04-25 |
| (86) | Number | PCT/EP2015/069601 |
| Date | 2015-08-27 |
| (87) | Number | WO 2016/030444 |
| Date | 2016-03-03 |
| (30) | Number | Date | Country code |
| 14182468 | 2014-08-27 | EP |
| (72) |
CHARVIN, Delphine, FR
MANTEAU, Baptiste, FR
POMEL, Vincent, FR
CONQUET, Francois, FR
|
| (73) |
Prexton Therapeutics SA,
14 Chemin des Aulx, 1228 Plan les Ouates, Geneva,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Nauji chromono oksimo dariniai ir jų panaudojimas kaip metabotropinių gliutamato receptorių alosterinių moduliatorių |
| NOVEL CHROMONE OXIME DERIVATIVE AND ITS USE AS ALLOSTERIC MODULATOR OF METABOTROPIC GLUTAMATE RECEPTORS |
| Payment date | Validity (years) | Amount | |
| 2020-07-16 | 6 | 139.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2021-08-27 |